Bonnie L. Bassler - 20 Nov 2025 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/ Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
20 Nov 2025
Net transactions value
-$287,736
Form type
4
Filing time
24 Nov 2025, 16:05:34 UTC
Previous filing
30 Sep 2025
Next filing
02 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bassler Bonnie L Director 777 OLD SAW MILL RIVER ROAD, TARRYTOWN /s/ Bonnie L. Bassler 24 Nov 2025 0001683607

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $282,264 +760 +49% $371.40 2,308 20 Nov 2025 Direct F1
transaction REGN Common Stock Sale $570,000 -760 -33% $750.00 1,548 20 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -760 -50% $0.000000 756 20 Nov 2025 Common Stock 760 $371.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 2, 2025.
F2 On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.